Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles
- PMID: 1325367
- DOI: 10.1016/0922-4106(92)90028-t
Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles
Abstract
Cyclic nucleotide phosphodiesterase (PDE) activities were characterized in the cytosolic and post-nuclear membrane preparations of guinea pig cardiac ventricles. The cytosolic PDE activities were stimulated 5-fold by calmodulin (CaM) on both substrates (1 microM) and 1.2-fold by cGMP (5 microM) on cAMP hydrolysis. Conversely, in the membrane preparation, CaM only stimulated PDE activities 1.2- to 1.4-fold, but cGMP induced a 3-fold increase of the hydrolysis of cAMP. In both the cytosolic and the membrane preparations, the hydrolysis of cAMP was inhibited by 100 microM of either the PDE III inhibitor SK&F 94120 (27% and 31% respectively) or the PDE IV inhibitor rolipram (14% and 23% respectively). Four peaks were resolved from the cytosolic preparation by chromatography. Peak A and peak B hydrolyzed both cAMP and cGMP and were stimulated respectively by CaM and cGMP. Peak C and peak D selectively hydrolyzed cAMP. Peak C had an apparent Km value for cAMP of 3.3 microM and was inhibited by PDE IV inhibitors. Peak D showed an apparent Km value for cAMP of 0.43 microM and was inhibited by cGMP and by cardiotonic inhibitors of PDE III. Similar potencies of these inhibitors were observed in the membrane preparation. These results suggest that in guinea pig cardiac ventricles: (1) PDE I (CaM-activated) is almost exclusively cytosolic; (2) PDE II (cGMP-stimulated), PDE III (cGMP-inhibited and cardiotonic-sensitive) and PDE IV (rolipram-sensitive) are present in cytosolic and membrane preparations; (3) PDE III and PDE IV differ in their apparent Km values for cAMP. The latter observation could explain the differential effects of PDE III and PDE IV inhibitors in the regulation of cardiac contraction.
Similar articles
-
Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.Circ Res. 1991 Apr;68(4):1070-9. doi: 10.1161/01.res.68.4.1070. Circ Res. 1991. PMID: 1849058
-
The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.Biochem J. 1987 Jan 15;241(2):535-41. doi: 10.1042/bj2410535. Biochem J. 1987. PMID: 3036066 Free PMC article.
-
Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.Am J Physiol. 1992 Mar;262(3 Pt 2):H654-60. doi: 10.1152/ajpheart.1992.262.3.H654. Am J Physiol. 1992. PMID: 1373036
-
Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase.Am J Cardiol. 1989 Jan 3;63(2):2A-8A. doi: 10.1016/0002-9149(89)90384-6. Am J Cardiol. 1989. PMID: 2535910 Review.
-
[Molecular cardiopharmacology of selective inhibitors of cyclic nucleotide phosphodiesterase isozymes].Nihon Yakurigaku Zasshi. 1992 Sep;100(3):249-58. doi: 10.1254/fpj.100.249. Nihon Yakurigaku Zasshi. 1992. PMID: 1328001 Review. Japanese.
Cited by
-
Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.Circulation. 2006 May 9;113(18):2221-8. doi: 10.1161/CIRCULATIONAHA.105.599241. Epub 2006 May 1. Circulation. 2006. PMID: 16651469 Free PMC article.
-
Local response of L-type Ca(2+) current to nitric oxide in frog ventricular myocytes.J Physiol. 2001 Jul 1;534(Pt 1):109-21. doi: 10.1111/j.1469-7793.2001.00109.x. J Physiol. 2001. PMID: 11432996 Free PMC article.
-
Compartmentalized cAMP signaling in cardiac ventricular myocytes.Cell Signal. 2022 Jan;89:110172. doi: 10.1016/j.cellsig.2021.110172. Epub 2021 Oct 20. Cell Signal. 2022. PMID: 34687901 Free PMC article. Review.
-
Role of PDE4 Family in Cardiomyocyte Physiology and Heart Failure.Cells. 2025 Mar 20;14(6):460. doi: 10.3390/cells14060460. Cells. 2025. PMID: 40136709 Free PMC article. Review.
-
Long lasting anti-adrenergic effect of 7-oxo-prostacyclin in the heart: a cycloheximide sensitive increase of phosphodiesterase isoform I and IV activities.Mol Cell Biochem. 1994 Mar 16;132(1):57-67. doi: 10.1007/BF00925675. Mol Cell Biochem. 1994. PMID: 8078509